Updated Jul 16, 2026
Thornberry Nancy has filed 3 SEC Form 4 filings across 3 companies in the last 90 days.
Nancy Thornberry is a corporate executive and director known for her role at Vertex Pharmaceuticals. She has extensive experience in the biotechnology and pharmaceutical industries, contributing to strategic decisions and governance at Vertex.
| Role | Director |
|---|---|
| Notability | 70/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-23 | SDGR | Schrodinger, Inc. | A — Grant or award | 8.1K | $0.00 | |
| 2026-06-05 | DNLI | Denali Therapeutics Inc. | A — Grant or award | 6.4K | $0.00 | |
| 2026-05-05 | VRTX | VERTEX PHARMACEUTICALS INC / MA | D — Derivative transaction | 398 | — | |
| 2026-05-05 | VRTX | VERTEX PHARMACEUTICALS INC / MA | A — Grant or award | 472 | $0.00 |
Nancy Thornberry is a corporate executive and director known for her role at Vertex Pharmaceuticals. She has extensive experience in the biotechnology and pharmaceutical industries, contributing to strategic decisions and governance at Vertex.…
3 primary Form 4 filings in the last 90 days, covering 3 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Thornberry Nancy profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.